Síndrome de iris fláccido por tamsulosinaEstudio prospectivo frente a grupo control

  1. A. Bidaguren
  2. C. Irigoyen
  3. J. Mendicute
  4. E. Gutiérrez
  5. A. Gibelalde
  6. M. Úbeda
Journal:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Year of publication: 2007

Volume: 82

Issue: 6

Pages: 349-354

Type: Article

DOI: 10.4321/S0365-66912007000600006 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Archivos de la Sociedad Española de Oftalmologia

Abstract

Objective: The main objectives of this study were: To assess the incidence of the intraoperative floppy-iris syndrome associated with tamsulosin and to analyse the incidence of intraoperative and postoperative complications as compared to a control group. Secondary objectives were: to describe the pupillary modifications associated with tamsulosin and to quantify the endothelial cell loss. Methods: A prospective review of 38 eyes of 38 patients was performed. Patients were assigned to two different groups. Group 1 (cases) included 19 eyes of 19 male patients taking tamsulosin, and group 2 (controls) included 19 eyes of 19 male patients not taking tamsulosin. Results: Only two patients (10%) of our study had the complete triad seen in floppy-iris syndrome; 9 patients (47%) showed 2 of the 3 main features of the syndrome and only 2 patients showed iris billowing during phacoemulsification. None of the patients in group 2 showed any of the characteristic intraoperative features. The complication rate was similar in both groups. Conclusions: Intraoperative floppy-iris syndrome occurred in 67% of the patients treated with tamsulosin. The only postoperative secondary effect was a lower pupil reactivity in patients taking tamsulosin.

Bibliographic References

  • Vasavada, A, Singh, R. (2000). Phacoemulsification in eyes with a small pupil. J Cataract Refract Surg. 26. 1210-1218
  • Chang, DF, Campbell, JR. (2005). Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 31. 664-673
  • Kershner, RM. (2005). Intraoperative floppy iris syndrome associated with tamsulosin: Letter. J Cataract Refract Surg. 31. 2239
  • Nguyen, DQ, Sebastian, RT, Kyle, G. (2005). Intraoperative floppy iris syndrome associated with tamsulosin: Letter. J Cataract Refract Surg. 31. 2240
  • Nguyen, DQ, Sebastian, RT, Philip, J. (2006). Intraoperative floppy iris syndrome associated with tamsulosin: Letter. BJU Int. 97. 197-199
  • Lawrentschuk, N, Bylsma, G. (2006). Intraoperative floppy iris syndrome and its relationship to tamsulosin: a urologist’s guide. BJU Int. 97. 2-4
  • Schwinn, DA, Afshari, NA. (2005). Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg?. Ophthalmology. 112. 2059-2060
  • Wikberg-Matsson, A, Uhlen, S, Wikberg, JE. (2000). Characterization of alpha1-adrenoceptor subtypes in the eye. Exp Eye Res. 70. 51-60
  • O’leary, MP. (2001). Tamsulosin: current clinical experience. Urology. 58. 42-48
  • Chapple, CR. (2005). The oral controlled absorption system (OCAS): the evolution of tamsulosin for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Eur Urol Suppl. 4. 20-22
  • Djavan, B. (2004). Alpha-1 adrenoceptor antagonists for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): state of the art. Eur Urol Suppl. 3. 23-30
  • Debruyne, FM. (2000). Alpha blockers: are all created equal?. Urology. 56. 20-22
  • Arshinoff, SA. (2006). Modified SST-USST for tamsulosin-associated intraocular floppy-iris syndrome. J Cataract Refract Surg. 32. 559-561
  • Walkow, T, Anders, N, Klebe, S. (2000). Endothelial cell loss after phacoemulsification: relation to preoperative and intraoperative parameters. J Cataract Refract Surg. 26. 727-732
  • Cheung, CM, Awan, MA, Sandramouli, S. (2006). Prevalence and clinical findings of tamsulosin-associated intraoperative floppy-iris syndrome. J Cataract Refract Surg. 32. 1336-1339
Data source: Dialnet